{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:01:09Z","timestamp":1767999669534,"version":"3.49.0"},"reference-count":23,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100013116","name":"Merz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["alz-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Alzheimer's &amp;amp; Dementia"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Communication problems are common in Alzheimer's disease (AD) patients, but instruments to assess these symptoms are limited. Our objective was to create a new scale, based on the language subscale of the Severe Impairment Battery (SIB), as a sensitive and reliable measurement of treatment effects on language performance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All 24 items of the SIB language subscale were chosen for analysis. Baseline scores of 1320 moderate\u2010to\u2010severe patients (Mini\u2010Mental State Examination [MMSE] score, &lt;15), from a combined AD database of four Memantine clinical trials (Study Codes: IE\u20102101, MEM\u2010MD\u201001, MEM\u2010MD\u201002, and MRZ\u20109605), were used for item reduction according to a standard principal components factor analysis. All items with loadings &gt;0.5 on the identified factors were selected for inclusion in the new language scale. Correlations with existing AD scales were examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The analysis indicated six factors, with 21 of 24 items showing loadings &gt;0.5. The resulting 21\u2010item SIB Language (SIB\u2010L) scale exhibited high internal consistency (Cronbach's \u03b1 = 0.809). The maximal SIB\u2010L score was 41 points, with a measurement error of 3.7 points. The stratification of baseline SIB\u2010L scores (mean, 31.7; SD, 8.4) by MMSE scores (mean, 9.7; SD, 3.3) showed a high variance in SIB\u2010L scores. This confirms that patients with a low MMSE score can possess preserved language abilities. The SIB\u2010L scale did not exhibit substantial floor\u2010and\u2010ceiling effects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The new SIB\u2010L is a fast (&lt;15 minutes) and easily administered scale with favorable psychometric characteristics for assessing language impairment and treatment effects on the language performance of patients with moderate to severe AD.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.jalz.2009.04.1236","type":"journal-article","created":{"date-parts":[[2009,9,13]],"date-time":"2009-09-13T04:09:38Z","timestamp":1252814978000},"page":"375-379","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Severe Impairment Battery Language scale: A language\u2010assessment tool for Alzheimer's disease patients"],"prefix":"10.1002","volume":"5","author":[{"given":"Steven","family":"Ferris","sequence":"first","affiliation":[{"name":"Alzheimer's Disease Center New York University School of Medicine New York NY"},{"name":"and Nathan Kline Institute Orangeburg NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Ihl","sequence":"additional","affiliation":[{"name":"Department of Psychiatry University of D\u00fcsseldorf and Department of Geriatric Psychiatry Alexian Hospital Krefeld Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Robert","sequence":"additional","affiliation":[{"name":"Memory Center CHU \u2010 University of Nice Sophia Antipolis Nice France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt","family":"Winblad","sequence":"additional","affiliation":[{"name":"Alzheimer Center Karolinska Institutet Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudrun","family":"Gatz","sequence":"additional","affiliation":[{"name":"Merz Pharmaceuticals Frankfurt am Main Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Tennigkeit","sequence":"additional","affiliation":[{"name":"Merz Pharmaceuticals Frankfurt am Main Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Gauthier","sequence":"additional","affiliation":[{"name":"McGill Centre for Studies in Aging McGill University Montreal Quebec Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,9]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"37","article-title":"Alzheimer's dementia. Coping with communication decline","volume":"15","author":"Hendryx\u2010Bedalov P.M.","year":"2000","journal-title":"J Gerontol Nurs"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-9-199511010-00007"},{"key":"e_1_2_6_4_2","first-page":"919","article-title":"Cognitive status and analgesic provision in nursing home residents","volume":"54","author":"Closs S.J.","year":"2004","journal-title":"Br J Gen Pract"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2318-6-3"},{"key":"e_1_2_6_6_2","first-page":"364","article-title":"Assessment of pain in elders with dementia","volume":"13","author":"Tsai P.F.","year":"2004","journal-title":"Med Surg Nurs"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1093\/geronb\/60.1.S48","article-title":"Investigating the effects of communication problems on caregiver burden","volume":"60","author":"Savundranayagam M.Y.","year":"2005","journal-title":"J Gerontol [B] Psychol Sci Soc Sci"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2002.00356.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610205002942"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-9452(08)70193-X"},{"key":"e_1_2_6_11_2","volume-title":"Functional Linguistic Communication Inventory","author":"Bayles K.","year":"1996"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1037\/1040-3590.2.3.298"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-200511000-00011"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1994.00540130067012"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199700112-00008"},{"issue":"1","key":"e_1_2_6_16_2","first-page":"49","article-title":"Efficacy of Memantine in patients with moderately severe to severe Alzheimer's disease in Japan (dose\u2010finding study)","volume":"14","author":"Homma A.","year":"2007","journal-title":"Eur J Neurol"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/WAD.0b013e318065c495","article-title":"Malca Resnick E. A 24\u2010week randomized, controlled trial of Memantine in patients with moderate\u2010to\u2010severe Alzheimer disease","volume":"14","author":"Dyck C.H.","year":"2007","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.3.317"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013128"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"e_1_2_6_21_2","first-page":"653","article-title":"Functional assessment staging (FAST)","volume":"24","author":"Reisberg B.","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.12.2308"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials\u00a0in Alzheimer's disease","volume":"11","author":"Galasko D.","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000081292","article-title":"Process of measuring in clinical medicine\u2014implications of different definitions in clinical therapeutic studies","volume":"70","author":"Beckerling A.","year":"2004","journal-title":"Digestion"}],"container-title":["Alzheimer's &amp; Dementia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1552526009013508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1552526009013508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.jalz.2009.04.1236","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.jalz.2009.04.1236","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1016\/j.jalz.2009.04.1236","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.jalz.2009.04.1236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T14:47:30Z","timestamp":1759934850000},"score":1,"resource":{"primary":{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/10.1016\/j.jalz.2009.04.1236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1016\/j.jalz.2009.04.1236"],"URL":"https:\/\/doi.org\/10.1016\/j.jalz.2009.04.1236","archive":["Portico"],"relation":{},"ISSN":["1552-5260","1552-5279"],"issn-type":[{"value":"1552-5260","type":"print"},{"value":"1552-5279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"2009-09-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}